A validated integrated clinical and molecular glioblastoma long-term survival-predictive nomogram

BACKGROUND: Glioblastoma (GBM) is the most common primary malignant brain tumor in adulthood. Despite multimodality treatments, including maximal safe resection followed by irradiation and chemotherapy, the median overall survival times range from 14 to 16 months. However, a small subset of GBM pati...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Neurooncol Adv
Главные авторы: Ferguson, Sherise D, Hodges, Tiffany R, Majd, Nazanin K, Alfaro-Munoz, Kristin, Al-Holou, Wajd N, Suki, Dima, de Groot, John F, Fuller, Gregory N, Xue, Lee, Li, Miao, Jacobs, Carmen, Rao, Ganesh, Colen, Rivka R, Xiu, Joanne, Verhaak, Roel, Spetzler, David, Khasraw, Mustafa, Sawaya, Raymond, Long, James P, Heimberger, Amy B
Формат: Artigo
Язык:Inglês
Опубликовано: Oxford University Press 2020
Предметы:
Clinical Investigations
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC7780842/
https://ncbi.nlm.nih.gov/pubmed/33426529
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/noajnl/vdaa146
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы